Literature DB >> 1910478

Activating point mutations of the gsp oncogene in human thyroid adenomas.

C O'Sullivan1, C M Barton, S L Staddon, C L Brown, N R Lemoine.   

Abstract

The gene for the alpha polypeptide chain (alpha s) of the heterotrimeric G protein Gs can be activated to the putative oncogene gsp by specific point mutations at codons 201 and 227. Such mutations have been reported in 40% of human growth hormone-secreting pituitary adenomas and in a single autonomously functioning thyroid adenoma. We examined an archival series of 45 differentiated human thyroid tumors by polymerase chain reaction amplification and oligonucleotide hybridization to identify point mutations at each of the affected codons. Successful amplification was achieved in 38 cases, and activating mutations were identified in 5 of 13 (38%) autonomously functioning adenomas, but in none of 16 nonfunctioning adenomas, six papillary carcinomas, or three follicular carcinomas. Our results confirm that the gsp oncogene is involved in the pathogenesis of autonomously functioning tumors but do not support a role in other thyroid tumors.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1910478     DOI: 10.1002/mc.2940040503

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  18 in total

Review 1.  Predictors of thyroid tumor aggressiveness.

Authors:  O H Clark
Journal:  West J Med       Date:  1996-09

Review 2.  Molecular insights into TSH receptor abnormality and thyroid disease.

Authors:  D Russo; F Arturi; E Chiefari; S Filetti
Journal:  J Endocrinol Invest       Date:  1997-01       Impact factor: 4.256

3.  Role of ras and gsp oncogenes in human epithelial thyroid tumorigenesis.

Authors:  J A Du Villard; M Schlumberger; R Wicker; B Caillou; P Rochefort; J Feunteun; R Monier; C Parmentier; H G Suarez
Journal:  J Endocrinol Invest       Date:  1995-02       Impact factor: 4.256

4.  Overexpression of Gs alpha subunit in thyroid tumors bearing a mutated Gs alpha gene.

Authors:  V N Gorelov; K Dumon; N S Barteneva; D Palm; H D Röher; P E Goretzki
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

Review 5.  Oncogenes and anti-oncogenes in human epithelial thyroid tumors.

Authors:  S Said; M Schlumberger; H G Suarez
Journal:  J Endocrinol Invest       Date:  1994-05       Impact factor: 4.256

6.  GNAS(R201H) and Kras(G12D) cooperate to promote murine pancreatic tumorigenesis recapitulating human intraductal papillary mucinous neoplasm.

Authors:  K Taki; M Ohmuraya; E Tanji; H Komatsu; D Hashimoto; K Semba; K Araki; Y Kawaguchi; H Baba; T Furukawa
Journal:  Oncogene       Date:  2015-08-10       Impact factor: 9.867

7.  Oncogenic potential of guanine nucleotide stimulatory factor alpha subunit in thyroid glands of transgenic mice.

Authors:  F M Michiels; B Caillou; M Talbot; F Dessarps-Freichey; M T Maunoury; M Schlumberger; L Mercken; R Monier; J Feunteun
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-25       Impact factor: 11.205

8.  G protein mutations in pituitary tumors: a study on Turkish patients.

Authors:  Beki Kan; Christopher Esapa; Tammam Sipahi; Cevdet Nacar; Fahir Ozer; Nur Buyru Sayhan; Mehmet Yaşar Kaynar; Ali Cetin Sarioğlu; Philip Edward Harris
Journal:  Pituitary       Date:  2003-09       Impact factor: 4.107

9.  Allelotyping of follicular thyroid tumors.

Authors:  J Zedenius; G Wallin; A Svensson; L Grimelius; A Höög; G Lundell; M Bäckdahl; C Larsson
Journal:  Hum Genet       Date:  1995-07       Impact factor: 4.132

10.  Genetics of papillary thyroid cancer initiation: implications for therapy.

Authors:  James A Fagin
Journal:  Trans Am Clin Climatol Assoc       Date:  2005
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.